Robustly predicting outcome for cancer patients from gene expression is an important challenge 24 on the road to better personalized treatment. Network-based outcome predictors (NOPs), which 25 considers the cellular wiring diagram in the classification, hold much promise to improve 26 42 SyNet is highly enriched for known breast cancer genes and genes related to e.g. histological 43 grade and tamoxifen resistance, suggestive of a role in determining breast cancer outcome. 44 45 Author Summary 48 Cancer is caused by disrupted activity of several pathways. Therefore, outcome predictors 49 analyze patient's expression profiles from perspective of gene groups collected from interactomes 50 (e.g. protein interaction networks). These Network based Outcome Predictors (NOPs) hold 51 3 potential to facilitate identification of dysregulated pathways and delivering improved prognosis. 52
performance, stability and interpretability of identified marker genes. Problematically, reports on 27 the efficacy of NOPs are conflicting and for instance suggest that utilizing random networks 28 performs on par to networks that describe biologically relevant interactions. In this paper we turn 29 the prediction problem around: instead of using a given biological network in the NOP, we aim to 30 identify the network of genes that truly improves outcome prediction. To this end, we propose 31 SyNet, a gene network constructed ab initio from synergistic gene pairs derived from survival-32 labelled gene expression data. To obtain SyNet, we evaluate synergy for all 69 million pairwise 33 combinations of genes resulting in a network that is specific to the dataset and phenotype under 34 study and can be used to in a NOP model. We evaluated SyNet and 11 other networks on a 35 compendium dataset of >4000 survival-labelled breast cancer samples. For this purpose, we used 36 cross-study validation which more closely emulates real world application of these outcome 37 predictors. We find that SyNet is the only network that truly improves performance, stability and 38 interpretability in several existing NOPs. We show that SyNet overlaps significantly with existing 39 gene networks, and can be confidently predicted (~85% AUC) from graph-topological descriptions 40 of these networks, in particular the breast tissue-specific network. Due to its data-driven nature, 41
SyNet is not biased to well-studied genes and thus facilitates post-hoc interpretation. We find that 103 In recent years, a range of improvements to the original NOP formulation has been proposed. In 104 the prediction step, various linear and nonlinear classifiers have been evaluated [26, 27] . 105
Problematically, the reported accuracies are often an overestimation as many studies neglected 106 to use cross-study evaluation scheme which more closely resembles the real world application of 107 these models [7] . Also for the aggregation step which is responsible for forming meta-genes from 108 gene sets several distinct approaches are proposed, such as clustering [23] and greedy 109 expansion of seed genes into subnetworks [18] . Moreover, in addition to simple averaging, 110 alternative means by which genes can be aggregated, such as linear or nonlinear embeddings, 111 have been proposed [17, 28] . Most recent work combines these steps into a unified model [8, 29] . 112 113 Despite these efforts and initial positive findings, there is still much debate over the utility of NOPs 114 compared to classical methods, with several studies showing no performance improvement 115 [21, 30, 31] . Perhaps even more striking is the finding that utilizing a permuted network [31] or 116 aggregating random genes [10] performs on par with networks describing true biological 117 relationships. Several meta-analyses attempting to establish the utility of NOPs have appeared 118 with contradicting conclusions. Notably, Staiger et al. compared performance of nearest mean 119 classifier [32] in this setting and concluded that network derived meta-genes are not more 120 predictive than individual genes [21, 31] . This is in contradiction to Roy et al. who achieved 121 improvements in outcome prediction when genes were ranked according to their t-test statistics 122 compared to their pagerank property [33] in PPI network [28, 34] . It is thus still an open question 123 whether NOPs truly improve outcome prediction in terms of predictive performance, cross-study 124 robustness or interpretability of the gene signatures. 125 126 A critical -yet often neglected -aspect in the successful application of NOPs is the contribution 127 of the biological network. In this regard, it should be recognized that many network links are 6 unreliable [35, 36] , missing [37] or redundant [38] and considerable efforts are being made to 129 refine these networks [37, [39] [40] [41] ]. In addition, many links in these networks are experimentally 130 obtained from model organisms and therefore may not be functional in human cells [42] [43] [44] . 131
Finally, most biological networks capture only a part of a cell's multifaceted system [45] . This 132 incomplete perspective may not be sufficient to link the wide range of aberrations that may occur 133 in a complex and heterogeneous disease such as breast cancer [46, 47] . Taken together, these 134 issues raise concerns regarding the extent to which the outcome predictors may benefit from 135 inclusion of common biological networks in their models. 136
137
In this work, we propose to construct a network ab initio that is specifically designed to improve 138 outcome prediction in terms of cross-study generalization and performance stability. To achieve 139 this, we will effectively turn the problem around: instead of using a given biological network, we 140 aim to use the labelled gene expression datasets to identify the network of genes that truly 141 improves outcome prediction (see are formed (f) and then integrated into meta-genes (typically using averaging) (g). The 150 constructed meta-genes are then used as regular features to train standard classifiers (h). The 151 phenotype of interest is patient outcome (i.e. 5-year survival). 152 7 Our approach relies on the identification of synergistic gene pairs, i.e. genes whose joint 154 prediction power is beyond what is attainable by both genes individually [48] . To identify these 155 pairs, we employed grid computing to evaluate all 69 million pairwise combinations of genes. The 156 resulting network, called SyNet, is specific to the dataset and phenotype under study and can be 157 used to successfully infer a NOP model. 158
159
To obtain SyNet, and allow for rigorous cross-study validation, a dataset of substantial size is 160 required. For this reason, we combined 14 publicly available datasets to form a compendium 161 encompassing 4129 samples. To the best of our knowledge, the data combined in this study 162 represents the largest breast cancer gene expression compendium to date. Further, to ensure 163 unbiased evaluation, sample assignments in the inner as well as the outer cross-validations folds 164 are kept equal across all assessments throughout the paper. 165
166
In the remainder of this paper, we will demonstrate that integrating genes based on SyNet 167 provides superior performance and stability of predictions when these models are tested on 168 independent cohorts. In contrast to previous reports, where shuffled versions of networks also 169 performed well, we show that the performance drops substantially when SyNet links are shuffled, 170 suggesting its connections are truly informative. We further evaluate the content and structure of 171 SyNet by overlaying it with known genesets and existing networks, revealing marked enrichment 172 for known breast cancer prognostic markers. While overlap with existing networks is highly 173 significant, the majority of direct links in SyNet is absent from these networks. Interestingly, they 174 can be reliably predicted from existing networks when more complex topological descriptions are 175 taken into account. Taken together, our findings suggest that compared to generic gene networks, 176 phenotype specific networks, which are derived directly from labeled data, can provide superior 177 performance while at the same time revealing valuable insight into etiology of breast cancer. 178 2 Results
180

SyNet improves NOP performance 181
We first evaluated NOP performance for three existing methods (Park, Chuang and Taylor) The GL clearly outperforms all other methods, in particular when it exploits the information 195 contained in SyNet. This corroborates our previous finding [8] that existing methods which 196 construct meta-genes by averaging are suboptimal (see S1 for a more extensive analysis). The 197 GL using the Corr network also outperforms the baseline model, albeit non-significantly (p~0.6), 198 which is in line with previous reports [23] . It should be noted that across all these experiments an 199 identical set of samples is used to train the models so that any performance deviation must be 200 due to differences in (i) the set of utilized genes or (ii) the integration of the genes into meta-201 genes. In the next two sections, we will investigate these factors in more details. 202 203
SyNet provides feature selection capabilities 204
Networks only include genes that are linked to at least one other gene. As a result, networks can 205 provide a way of ranking genes based on the number and weight of their connections. One 206 explanation for why NOPs can outperform regular classifiers is that networks provide an a priori 207 gene (feature) selection [31] . To test this hypothesis and determine the feature selection 208 capabilities of SyNet, we compare classification performances obtained using the baseline 209 classifier (i.e. Lasso) that is trained using enclosed genes in each network. While this classifier 210 performs well (see S3 for details), it cannot exploit information contained in the links of given 211 network. So any performance difference must be due to the genes in the network. The number of 212 genes in the network was varied by thresholding the weighted edges in the network and removing 213 unconnected genes. The edge weight threshold and the Lasso regularization parameter were 214 determined using a cross-validated grid search (see S5 for details). The results presented in Figure 3 .a demonstrate that SyNet is the only network that performs 228 significantly better than the baseline model which is trained on all genes. Interestingly, we observe 229 that SyNet is the top performing network while utilizing a comparable number of genes to other 230 networks. The second-best network is the Corr network. Compared to the Corr network, SyNet 231 additionally had access to label information, making it also specific to the class label under study. 232
It should be noted that the data on which SyNet and the Corr networks are constructed are 233 completely independent from the validation data on which the performance is based due to our 234 multi-way cross-validation scheme (see Methods and S5). We conclude that dataset specific 235 networks, in particular SyNet which also exploits label information, provides a meaningful feature 236 selection that is beneficial for classification performance. 237
238
Our result show that none of the tissue specific networks outperform the baseline. Despite the 239 modest performance, it is interesting to observe that performance for these networks increases 240 as more relevant tissues (e.g. breast and lymph node networks) are utilized in the classification. 241
Additionally, we observe that tissue specific networks do not outperform the generic networks. 242
This may be the result of the fact that generic networks predominantly contain broadly expressed 243 genes with fundamental roles in cell function which may still be relevant to survival prediction. A 244 similar observation was made for GWAS where SNPs in these widely-expressed genes can 245 explain a substantial amount of missed heritability [59] . 246
247
In addition to classifier performance, an important goal of employing NOPs is to identify stable 248 gene signatures, that is, the same genes are selected irrespective of the study used to train the 249 models. Gene signature stability is necessary to confirm that the identified genes are independent 250 of dataset specific variations and are true biological drivers of the disease. To measure the 251 signature consistency, we assessed the overlap of selected genes across all repeats and folds 252 using the Jaccard Index. Figure 3 .b shows that, using genes included in SyNet, Lasso identifies 253 more similar genes across folds and studies compared to other networks. Surprisingly, despite the signature stability for SyNet is markedly better than for generic or tissue specific networks, in 256 which the genes are fixed. Therefore, our results demonstrate that synergistic genes in SyNet 257 truly aid the classifier to robustly select signatures across independent studies. 258 259
SyNet connections are beneficial for NOP 260
The ultimate goal of employing NOPs compared to classical models that do not use network 261 information is to improve prognosis prediction by harnessing the information contained in the links 262 of the given network. Therefore, we next aimed to assess to what extend also connections 263 between the genes, as captured in SyNet and other networks, can help NOPs to improve their 264 performance beyond what is achievable using individual genes. As before, we utilized identical 265
datasets (in terms of genes and samples) in inner and outer cross-validation loops to train all four 266
NOPs as well as the baseline model which uses Lasso. As a result, in our comparison, the only 267 difference between each NOP and the regular Lasso is the grouping of genes based on their 268 connectivity in the networks. 269
270
Our results, presented in Figure 4 .a, clearly demonstrate that SyNet is the only network to achieve 271 superior prognostic prediction for unseen patients from an independent cohort. It outperforms all 272 other tested networks, including relevant tissue specific networks. Moreover, we find that using 273
SyNet also provides one of the largest gains in performance over its Lasso counterpart ( Figure  274 
4.b, x-axis), indicating that the links between genes in SyNet truly aid classification performance 275
beyond what is obtained as a result of the feature selection capabilities. 276 To confirm that NOP performance using SyNet is the result of the network structure, we also 287 applied the GL to a shuffled version of SyNet (Figure 4.a) . We observe a substantial deterioration 288 of the AUC supporting the conclusion that not only the genes, but also links contained in SyNet 289 are relevant to achieve good prediction. Moreover, this observation rules out that the GL by itself 290 is able to provide enhanced performance compared to standard Lasso. Result of similar 291 assessment for Corr network is given in (Figure S12) . 292 293 Another important property of an outcome predictor is to yield comparable performance 294 irrespective of dataset used for training the model (i.e. performance stability). This is a highly 295 desirable quality, as concerns have been raised regarding the highly variable performances of 296 breast-cancer classifiers applied to different cohorts [7, 60] . We further compared performances when each network contains equal number of links and 301 observe a similar trend in performance (see S7 for details). We also considered the more complex Sparse Group Lasso (SGL), which offers an additional level of regularization. No substantial 303 difference between GL and SGL performance was found (see S8 for details). Likewise, we did 304 not observe substantial performance differences when the number of genes, group size and 305 regularization parameters were simultaneously optimized in a grid search (see S9 for details). 306
Together, these findings can be considered as the first unbiased evidence of true classification 307 performance improvement in terms of average AUC and classification stability by a NOP. 308 309
Gene enrichment analysis for SyNet 310
Many curated biological networks suffer from bias since genes with well-known roles are the 311 subject of more experiments and thus get more extensively and accurately annotated [61] . Post-312 hoc interpretation of the features used by NOPs, often by means of an enrichment analysis, will 313 therefore be affected by the same bias. SyNet does not suffer from such bias, as its inference is 314 purely data driven. Moreover, since SyNet is built based on gene pairs that contribute to the 315 prediction of clinical outcome, we expect that the genes included in the network not only relate to 316 breast cancer; they should play a role in determining how aggressively the tumor behaves, how 317 advanced the disease is or how well it responds to treatment. 318 319 To investigated the relevance of genes contained in SyNet in the development of breast cancer 320 and, more importantly, clinical outcome, we ranked all pairs according to their median Fitness 321 ( ) across 14 studies and selected the top 300 genes (encompassing 3544 links). This cutoff 322 was frequently chosen by the Lasso as the optimal number of genes in SyNet (see section 3.1). 323 In summary, SyNet predominantly appears to contain genes relevant to two main processes in 375 the progression of breast cancer: increased cell proliferation and the process of metastasis. 376 Although many genes have not previously been specifically linked to breast cancer prognosis, 377 their role in regulating different stages of replication and mitosis points to a genuine biological role 378 in the progression and prognosis of breast cancer. 379
Similarity of SyNet to existing biological networks 381
We next sought to investigate the similarity between SyNet and existing biological networks that 382 directly or indirectly capture biological interactions. To enable a comparison with networks of 383 different sizes, we compare the observed overlap (both in terms of genes as well as links) to the 384 distribution of expected overlap obtained by shuffling each network 1000 times. Overlap is 385 determined for varying network sizes by thresholding the link weights such that a certain 386 percentage of genes or links remains. Results are reported in terms of a z-score in Figure 6 . 387 SyNet genes is contained in the top of each network. The overlap is especially pronounced for 396 the tissue specific networks, in particular the Breast and Lymph node specific network, supporting 397 our observation that SyNet contains links that are relevant for breast cancer. The enrichment 398 becomes even more significant when considering the overlap between the links (Figure 6.b) . In 399 this respect, SyNet also is clearly most similar to the Breast and Lymph node specific networks. 400
We confirmed that these enrichments are not only driven by the correlation component of SyNet 401
by repeating this analysis with the correlation component removed (see S10). It should moreover 402 be noted that, although a highly significant overlap is observed, the vast majority of SyNet genes 403 and links are not present in the existing networks, explaining the improved performance obtained the top 25% of genes (n=1005) in the Breast specific network, and 151 in the top 25% of genes 406 (n=1290) in the Lymph node specific network. Similarly, out of the 3544 links in SyNet, only 1182 407 are contained within the top 25% of links (n=12500) in the Breast specific network, and 617 in the 408 top 25% (n=12500) of the Lymph node specific network (see S11 for details). 409 410
Higher order structural similarity of SyNet and existing biological networks 411
In addition to direct overlap, we also aimed to investigate if genes directly connected in SyNet 412 may be indirectly connected in existing networks. To assess this for each pair of genes in SyNet, 413
we computed several topological measures characterizing their (indirect) connection in the 414 biological networks. We included degree (Figure 7.a 
Predicting SyNet links from biological networks 429
Encouraged by the overlap with existing biological networks, we next asked whether links in 430 characterized each gene-pair by a set of 12 graph-topological measures that describe local and 432 global network structure around each gene-pair. In addition to the degree, shortest path and 433 Jaccard, we included several additional graph-topological measures including direct link, page 434 rank (with four betas), closeness centrality, clustering coefficient and eigenvector centrality (see 435 supplementary text for details). While converting node-based measures to edge based measures, 436 in addition to using the average, we also used the difference between the score for each gene in 437 the pair, similar to our previous work [85] . We applied these measures to all 10 networks in our 438 collection yielding a total of 210 features. The gene-pairs are labeled according to their presence 439 or absence in SyNet. Inspection of this dataset using the t-SNE [57] reveals that the links in SyNet 440 occupy a distinct part of the 2D embedding obtained (Figure 8.a) . 441 where in each fold 1/50 of pairs in SyNet is kept hidden and the rest of pairs is utilized to train the 450 classifier. To avoid information leakage in this assessment, we removed gene pairs from the 451 training set in case one of the genes is present in the test set. Based on this analysis we find that 452 a simple linear classifier can reach ~85% accuracy in predicting the synergistic gene relationships 453 from SyNet (Figure 8.b, rightmost bar) . The contribution from generic networks is markedly 454 smaller than for the tissue specific networks. In particular the networks relevant to breast cancer 455 are highly informative, to the extent that combining multiple networks no longer improves 456 prediction performance. Further investigation of feature importance revealed that the page rank topological measure was commonly used as a predictive marker. Apparently, while direct overlap 458 between SyNet and existing networks is modest, the topology of the breast specific networks is 459 highly informative for the links contained in SyNet. This corroborates findings from Winter Here, we present a rigorously cross-validated procedure to train and validate Group Lasso-based 472
NOPs using a variety of networks, in particular also tissue specific networks, which have not been 473 evaluated in the context of NOPs before. 474
475
Based on our analyses we conclude that none of the existing networks achieve improved 476 performance compared to using properly regularized classifiers trained on all genes. In this work 477 we therefore present a novel gene network, called SyNet, which is computationally derived 478 directly from the labeled dataset. The links in SyNet connect synergistic gene pairs. We followed 479 a cross-validation procedure in which the inference of SyNet and validation of its utility in a NOP 480 is strictly separated. We find that SyNet-based NOPs yields superior performance with higher 481 stability across the folds compared to both the baseline model trained on all genes as well as 482 models that use other existing gene networks. We therefore conclude that networks can improve 483 outcome prediction, but only if this network is dataset specific and inferred from labeled training 484 data. The Corr network, which is also dataset specific but not inferred from labeled data, also 485 improved performance but much less than using SyNet. 486 487 A major benefit of SyNet over manually curated gene networks is that its inference is purely data 488 driven, and therefore not biased to well-studied genes. Post-hoc interpretation of the genes 489 selected by a NOP that utilized SyNet is therefore expected to provide a more unbiased 490 interpretation of the important molecular players underlying breast cancer and patient survival. 491
Analysis of the genes contained in SyNet shows strong enrichment for genes with known 492 relevance to breast cancer. More importantly, the largest subcomponent of SyNet is strongly 493 linked to patient prognosis because it includes many genes with a known relation to the 494 histological grade of the tumor. 495
496
To investigate if SyNet captures known biological gene interactions, we extensively compared 497 SyNet with existing networks. We find highly significant overlaps between links, indicating that 498 SyNet connects genes that also have a known biological interaction. Despite this significant 499 overlap, the majority of the SyNet links are not recapitulated by direct links in the existing 500 networks. However, we find that accurate predictions of links in SyNet are possible if more 501 complex graph topological descriptions of the indirect connections in the existing networks are 502 used. Interestingly, accurate predictions are only obtained when using the breast specific 503 networks. Apparently, although the information contained in SyNet is very similar to other gene 504 interaction networks, they can only be exploited by the classifier if they are connected in a certain 505 way. This might explain why using existing biological networks in NOPs directly is unsuccessful 506 and why using graph topological measures has been successful in identifying relevant genes in 507 outcome prediction [33, 34, 86] . poorly performing genes tend to achieve higher degree of synergy compared to two predictive 530 genes (see S2 for corresponding analysis). In order to account for this effect, the average AUC 531 of individual genes is included as a second criterion. Furthermore, our preliminary tests confirmed 532 previous findings [8, 23, 49 ], that integrating highly correlated genes (which reduces meta-gene 533 noise) may improve survival prediction. For this reason, we added correlation of pairs as a third 534 criterion. To combine these three measures, each measure is normalized and combined into an 535 overall fitness score for gene pair : supplementary text for details). Collectively, these datasets, spanning 14 distinct studies, form a 551 compendium encompassing 4129 samples. To the best of our knowledge, the data combined in 552 this paper represents the largest breast cancer gene expression compendium to date. As a result, 553 our compendium should capture a large portion of the biological heterogeneity among breast 554 cancer patients, as well as technical biases originating from the variability in platforms and study-555 specific sample preparations [52] . This variability will assist the trained models to achieve better 556 generalization which is crucial in real world application of the final classification model [9, 13, 53] . 557
To correct for technical variations that may arise during the library preparation, initially the 558 expression data within each study is quantile normalized and then batch-effect corrected using 559
Combat [54] where the outcome of patients was modeled as an additional covariate to maintain 560 the variance associated with the prognostics. This procedure was shown to perform well among 561 many batch effect removal methods [55, 56] . Successful removal of batch effects were confirmed 562 using t-SNE visualization [57] (See S4 for details). The label for each patient corresponds to 563 overall survival time (or recurrence free survival if available) with respect to a 5-year threshold 564 (good vs. poor outcome). 565 566
Regular classifiers and Network based prediction models 567
Ascertaining the relevance of networks in outcome prediction should be performed using a robust 568 predictor capable of providing adequate performance in prognostic prediction. Previous 569 assessments in this regard have been limited to only few classifiers [21, 23, 28, 34] . To identify the 570 optimal predictor, we have compared performance of wide range of linear and nonlinear classifiers 571 (see S3 for details). Supporting our previous findings [8] , this evaluation demonstrates that simple 572 linear classifiers outperform the more complex ones, with the regularized linear classifier (Lasso) 573 reaching the highest AUC. This classifier supports both classical and well as network based 574 prediction by its derivative called Group Lasso (GL) [58] . The GL is structurally analogous to 575 standard Lasso with the exception of the way in which the regularization is performed; Lasso 576 applies regularization to genes while GL enforces selection of groups of genes (See 577 supplementary text for details). In order to incorporate network information in the GL, similar to 578 our previous work [8] , each gene in the corresponding network is considered as seed gene and 579 together with its K neighbors the group structure provided to the GL. Priority of neighbor selection 580 is determined by edge weights between each neighbor and corresponding seed gene. The 581 hyperparameters for each classifier (e.g. K in the GL) are determined by means of a grid search 582 in the inner cross validation loop (see S5 for schematic overview). 583 In addition to SyNet, we considered a total of 12 other publicly available networks, including 600 generic networks (HumanInt, BioPlex, BioGRID, IntAct and STRING), tissue specific networks 601 [43] (brain, kidney, ovary, breast, lymph node) and a correlation network (Corr) which was 602 previously shown to be an effective network in outcome prediction [8, 23] . To the best of our 603 knowledge, our study is the first to evaluate tissue specific networks in the context of NOPs. To 604 maintain a reasonable network size, we utilized only the top 50,000 links (based on the link weight) 605 in each network (similar to number of links in SyNet). For the only unweighted network, HumanInt 606
[37], all interactions (n=~14k) were included and links were weighted according to the average 607 degree of the two interacting genes. Moreover, a randomized version of each network is 608 constructed by shuffling nodes in the network which destroys the biological information of the links 609 while preserving the overall network structure (see supplementary text for full details on 610 preparation of networks). 611 612
Cross validation design 613
In order to ascertain if network information truly aids outcome prediction, the evaluation should 614 be based on a rigorous cross-validation that closely resembles the real-world application of these 615 models. To this end, we perform cross-study validation in order to mimic a realistic situation in 616 which a classifier is applied to data from a different hospital than it was trained on [7] . Briefly, one This set is also used to infer correlation network. To assess the final performance of the NOP the 626 outer loop test set is used (see S5 for a detailed schematic). Our initial experiments showed a 627 large variation of performance across studies (see S6 for details). To prevent this variation from 628 influencing our comparisons, assignment of samples to folds in both inner and outer cross-629 validation loops are kept identical across all comparisons throughout the paper. We used Area 630
Under the ROC Curve (AUC) as the main measure of performance in this paper. 
